- ADC Therapeutics gewährt neuen Mitarbeitern Zuteilungen im Rahmen des Anreizplans
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
- ADC Therapeutics tritt demnächst den Indizes Russell 2000® und Russell 3000® bei
- ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
- ADC Therapeutics nimmt an der Jefferies Global Healthcare Conference teil
- ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
- ADC Therapeutics wird an der H.C. Wainwright 2nd Annual BioConnect Investor Conference an der NASDAQ teilnehmen
- ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
- ADC Therapeutics nimmt an der RBC Capital Markets Global Healthcare Conference 2024 teil
- ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
More ▼
Key statistics
On Wednesday, ADC Therapeutics SA (ADCT:NYQ) closed at 3.06, 750.24% above the 52 week low of 0.3599 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.52 |
---|---|
High | 3.57 |
Low | 3.00 |
Bid | 3.09 |
Offer | 3.24 |
Previous close | 3.48 |
Average volume | 1.66m |
---|---|
Shares outstanding | 96.19m |
Free float | 75.90m |
P/E (TTM) | -- |
Market cap | 334.74m USD |
EPS (TTM) | -2.77 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 22:00 BST.
More ▼